In the year prior to the start of the coronavirus pandemic, 15.8% of American adults were using prescription medication to support their mental health; two years later, that number has risen to 23%,...
On June 30, the FDA released a drug safety communication that warned against the risks associated with Copiktra. Copiktra, also called duvelisib, is a cancer drug used to treat relapsed or...
A former employee of Eli Lilly is suing the company, claiming she was terminated after exposing issues with pharmaceutical manufacturing practices at one United States operation. Amrit Mula said that...
FDA recently approved Eli Lilly and Company’s Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes as an addition to diet and...
Roche’s Global Access Program and the Global Fund to Fight AIDS, Tuberculosis, and Malaria, recently partnered to build and strengthen diagnostic capacity and pandemic preparedness in...
The Janssen Pharmaceutical Companies of Johnson & Johnson recently terminated its collaboration with Bavarian Nordic, which developed potential vaccines against the hepatitis B virus and human...
AstraZeneca recently announced plans to open a new drug research and development site at the heart of Cambridge, MA, for itself and Alexion’s new corporate headquarters.
The strategic center...
FDA is seeking public comment on a potential change that would require opioid analgesics used in outpatient settings to be dispensed with prepaid mail-back envelopes and that pharmacies provide patient...
GSK recently entered into a $1.9 billion agreement to acquire biopharmaceutical company Sierra Oncology to treat rare cancers.
Myelofibrosis is a rare blood cancer that causes considerable...
FDA recently issued an emergency use authorization (EUA) for the first COVID-19 test that detects chemical compounds in breath samples associated with SARS-CoV-2 infection.
Qualified,...
Sanofi recently launched its first-in-pharma Diversity, Equity, & Inclusion (DE&I) Board to encourage an inclusive and diverse culture that enables breakthrough innovations.
The...
Merck recently reaffirmed its commitment to enable broad equitable access to its human papillomavirus (HPV) vaccines.
Under the initiative, Merck will expand its vaccines manufacturing facility...
Moderna recently launched the Moderna Charitable Foundation to promote public health, access to quality healthcare, and educational opportunities, particularly in underserved populations.
The...
Gilead recently announced $24 million in grants to reduce health disparities, improve access to quality healthcare, advance medical education, and support local communities most impacted by the HIV and...
FDA recently amended the emergency use authorization of Moderna's COVID-19 vaccine to allow for a second booster dose at the 50 microgram level in adults 50 years of age and older.
The...
FDA recently issued a complete response letter (CRL) for Eli Lilly and Company’s biologics license application (BLA) for its combination antibody therapy, sintilimab, to treat nonsquamous...
Johnson & Johnson recently announced a series of initiatives in high tuberculosis (TB) burden countries to empower a generation of youth to end TB and increase disease detection.
The...
Novavax recently launched its global, unbranded vaccine programs, 'We Do Vaccines' and 'Know Our Vax' as educational efforts to help protect people's health in the fight against the...
FDA recently approved Boehringer Ingelheim's Jardiance to reduce the risk of cardiovascular death and hospitalization in heart failure in adults.
The agency based its approval on the safety and...
Boehringer Ingelheim and precision medicine software company Lifebit Biotech recently partnered to build a scalable data, analytics, and infrastructure platform to unlock the transformation value of...
